154 related articles for article (PubMed ID: 14629269)
21. Ki-67 is a prognostic marker for hormone receptor positive tumors.
Pérez-López ME; García-Gómez J; Alves MT; Paradela A; García-Mata J; García-Caballero T
Clin Transl Oncol; 2016 Oct; 18(10):996-1002. PubMed ID: 26742937
[TBL] [Abstract][Full Text] [Related]
22. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome.
Trastour C; Benizri E; Ettore F; Ramaioli A; Chamorey E; Pouysségur J; Berra E
Int J Cancer; 2007 Apr; 120(7):1451-8. PubMed ID: 17245699
[TBL] [Abstract][Full Text] [Related]
23. Enhanced mRNA expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in breast carcinomas is correlated with adverse prognosis.
Nakopoulou L; Giannopoulou I; Stefanaki K; Panayotopoulou E; Tsirmpa I; Alexandrou P; Mavrommatis J; Katsarou S; Davaris P
J Pathol; 2002 Jul; 197(3):307-13. PubMed ID: 12115876
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
[TBL] [Abstract][Full Text] [Related]
25. Ki67 expression in breast cancer. Correlation with prognostic markers and clinicopathological parameters in Saudi patients.
Elkablawy MA; Albasri AM; Mohammed RA; Hussainy AS; Nouh MM; Alhujaily AS
Saudi Med J; 2016 Feb; 37(2):137-41. PubMed ID: 26837394
[TBL] [Abstract][Full Text] [Related]
26. Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis.
Fernandez-Garcia B; Eiró N; Marín L; González-Reyes S; González LO; Lamelas ML; Vizoso FJ
Histopathology; 2014 Mar; 64(4):512-22. PubMed ID: 24117661
[TBL] [Abstract][Full Text] [Related]
27. COX-2 expression in human breast carcinomas: correlation with clinicopathological features and prognostic molecular markers.
Miglietta A; Toselli M; Ravarino N; Vencia W; Chiecchio A; Bozzo F; Motta M; Torchio B; Bocca C
Expert Opin Ther Targets; 2010 Jul; 14(7):655-64. PubMed ID: 20536410
[TBL] [Abstract][Full Text] [Related]
28. Potential clinical relevance of uPA and PAI-1 levels in node-negative, postmenopausal breast cancer patients bearing histological grade II tumors with ER/PR expression, during an early follow-up.
Buta M; Džodić R; Đurišić I; Marković I; Vujasinović T; Markićević M; Nikolić-Vukosavljević D
Tumour Biol; 2015 Sep; 36(10):8193-200. PubMed ID: 25994573
[TBL] [Abstract][Full Text] [Related]
29. Association of autotaxin and lysophosphatidic acid receptor 3 with aggressiveness of human breast carcinoma.
Popnikolov NK; Dalwadi BH; Thomas JD; Johannes GJ; Imagawa WT
Tumour Biol; 2012 Dec; 33(6):2237-43. PubMed ID: 22922883
[TBL] [Abstract][Full Text] [Related]
30. [Activation and prognostic significance of AKT, NF-kappaB and STAT3 in breast cancer with lymph node metastasis and estrogen receptor expression].
Liu C; Zhou S; Ke CS; Li NP; Wu RL
Ai Zheng; 2007 Sep; 26(9):929-36. PubMed ID: 17927847
[TBL] [Abstract][Full Text] [Related]
31. Expression of the vascular endothelial growth factor receptor-2/Flk-1 in breast carcinomas: correlation with proliferation.
Nakopoulou L; Stefanaki K; Panayotopoulou E; Giannopoulou I; Athanassiadou P; Gakiopoulou-Givalou H; Louvrou A
Hum Pathol; 2002 Sep; 33(9):863-70. PubMed ID: 12378509
[TBL] [Abstract][Full Text] [Related]
32. c-met tyrosine kinase receptor expression is associated with abnormal beta-catenin expression and favourable prognostic factors in invasive breast carcinoma.
Nakopoulou L; Gakiopoulou H; Keramopoulos A; Giannopoulou I; Athanassiadou P; Mavrommatis J; Davaris PS
Histopathology; 2000 Apr; 36(4):313-25. PubMed ID: 10759945
[TBL] [Abstract][Full Text] [Related]
33. [Expression and prognostic value of transcriptional factor sp1 in breast cancer].
Wang XB; Peng WQ; Yi ZJ; Zhu SL; Gan QH
Ai Zheng; 2007 Sep; 26(9):996-1000. PubMed ID: 17927860
[TBL] [Abstract][Full Text] [Related]
34. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R
Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689
[TBL] [Abstract][Full Text] [Related]
35. Expression of Stromal Caveolin- 1 May Be a Predictor for Aggressive Behaviour of Breast Cancer.
Eliyatkin N; Aktas S; Diniz G; Ozgur HH; Ekin ZY; Kupelioglu A
Pathol Oncol Res; 2018 Jan; 24(1):59-65. PubMed ID: 28236153
[TBL] [Abstract][Full Text] [Related]
36. High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer.
Min KW; Kim DH; Do SI; Pyo JS; Chae SW; Sohn JH; Kim K; Lee HJ; Kim DH; Oh S; Choi SH; Park YL; Park CH; Kwon MJ; Moon KM
Postgrad Med J; 2016 Dec; 92(1094):707-714. PubMed ID: 27222586
[TBL] [Abstract][Full Text] [Related]
37. Cyclin E amplification, over-expression, and relapse-free survival in HER-2-positive primary breast cancer.
Luhtala S; Staff S; Tanner M; Isola J
Tumour Biol; 2016 Jul; 37(7):9813-23. PubMed ID: 26810187
[TBL] [Abstract][Full Text] [Related]
38. Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer.
Grönberg M; Fjällskog ML; Jirström K; Janson ET
Acta Oncol; 2012 Mar; 51(3):386-93. PubMed ID: 22067021
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.
Grünwald B; Harant V; Schaten S; Frühschütz M; Spallek R; Höchst B; Stutzer K; Berchtold S; Erkan M; Prokopchuk O; Martignoni M; Esposito I; Heikenwalder M; Gupta A; Siveke J; Saftig P; Knolle P; Wohlleber D; Krüger A
Gastroenterology; 2016 Nov; 151(5):1011-1024.e7. PubMed ID: 27506299
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer.
Schoppmann SF; Schindl M; Bayer G; Aumayr K; Dienes J; Horvat R; Rudas M; Gnant M; Jakesz R; Birner P
Int J Cancer; 2003 May; 104(6):677-82. PubMed ID: 12640673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]